Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Most U.S. drugs rely on ingredients from China, raising safety, quality, and national security concerns. Experts call for ...

The pharmaceutical industry spends a ton of money on drug ads. This should come as no surprise to anyone who watches TV or ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

Inappropriate polypharmacy—the excessive or unnecessary use of multiple medications—is a major driver of emergency hospital ...

The Canada Pharmaceutical Market, valued at USD 51.56 billion in 2024, is projected to reach USD 76.9 billion by 2030, ...

GSK plc (NYSE:GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA ...

By Mariam Sunny and Mrinalika Roy (Reuters) -Shares of Gilead rose 3% after the U.S. Supreme Court on Friday upheld a federal ...

(Reuters) -Shares of Gilead rose nearly 3% after the U.S. Supreme Court on Friday preserved a key element of the Obamacare ...

The tolerability and safety profiles of GSK’s Blenrep combos align with the known profiles of the individual agents involved. Credit: ricochet64/Shutterstock. The European Medicines Agency’s (EMA) ...

“We are assessing the impact and working closely with the site to expedite resumption of operations,” the company said in the exchange filing. GSK Pharma is the Indian subsidiary of the ...